This Article Full Text Full Text (PDF) All Versions of this Article: 91/10/3713    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Modan-Moses, D. Articles by Anikster, Y. Search for Related Content PubMed PubMed Citation Articles by Modan-Moses, D. Articles by Anikster, Y. Related Collections Adrenal and Hypertension

Unusual Presentation of Familial Glucocorticoid Deficiency with a Novel MRAP Mutation

Pediatric Endocrinology Unit (D.M.-M., O.P.-H.), Pediatric Neurology Unit (B.B.-Z.), and Metabolic Disease Unit (Y.A.), The Edmond and Lily Safra Children’s Hospital, and Department of Diagnostic Imaging (C.H.), Sheba Medical Center, Tel-Hashomer 52621, Israel; Division of Medical Genetics (T.C.F.-Z.), Hospital of Western Galilee-Naharia, Naharia 22386 Israel; Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel; Department of Neonatology (Y.A.B.), Laniado Medical Center, Netanya 42150, Israel; and the Sackler School of Medicine (D.M.-M., B.B.-Z., O.P.-H., Y.A.), Tel Aviv University, Tel Aviv 69978, Israel

Address all correspondence and requests for reprints to: Dalit Modan-Moses, M.D., Division of Pediatrics, Chaim Sheba Medical Center, Tel-Hashomer 52621, Israel. E-mail: dmodan{at}sheba.health.gov.il.

Context: Mutations in MRAP, an interacting partner of the ACTH receptor, have been shown recently to cause familial glucocorticoid deficiency (FGD) in kindreds with confirmed FGD and no ACTH receptor mutations.

Objective: We describe a Jewish-Ethiopian family with FGD caused by a novel MRAP mutation.

Patients: Our index patient presented at the age of 19 months with hypocortisolism, severe psychomotor retardation, myoclonic seizures, spastic quadriparesis, and microcephaly. Before the definite diagnosis was made, a female sibling was born in another hospital and succumbed during the neonatal period due to sepsis and adrenal crisis.

Methods: DNA was extracted from peripheral blood samples from the index case and his mother and from fibroblasts obtained from the female patient. The DAX-1, ACTH receptor (MC2R), and MRAP genes were analyzed.

Results: The index patient was diagnosed with FGD and was found to be homozygous for a novel MRAP mutation, a seven-base deletion in exon 3 of the MRAP gene. This deletion causes a frame shift, resulting in a stop codon after 23 amino acids (L31X). Postmortem analysis of fibroblasts obtained from the female patient revealed that she harbored the same mutation.

Conclusions: This is the first report of MRAP mutations after the recent identification of the gene. Whether the novel MRAP mutation described by us is associated with a particularly severe phenotype remains to be investigated.

This article has been cited by other articles:

				C. V. A. Collares, J. Antunes-Rodrigues, A. C. Moreira, S. N. Franca, L. A. Pereira, M. M. S. Soares, J. Elias Junior, A. J Clark, M. de Castro, and L. L. K. Elias Heterogeneity in the molecular basis of ACTH resistance syndrome. Eur. J. Endocrinol., July 1, 2008; 159(1): 61 - 68. [Abstract] [Full Text] [PDF]